Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.2361
-0.0071-2.92%
Post-market: 0.23610.00000.00%16:29 EDT
Volume:194.24K
Turnover:46.60K
Market Cap:10.48M
PE:-0.14
High:0.2468
Open:0.2460
Low:0.2361
Close:0.2432
52wk High:5.14
52wk Low:0.1980
Shares:44.38M
Float Shares:41.42M
Volume Ratio:0.48
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6559
EPS(LYR):-1.8303
ROE:-166.46%
ROA:-83.21%
PB:0.43
PE(LYR):-0.13

Loading ...

Aug 17, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 10, 2022

Major Issues Report

8-K - Current report